"Designing Growth Strategies is in our DNA"

Middle East & Africa Botulinum Toxin Market Size, Share & Industry Analysis, By Application (Therapeutics {Chronic Migraine, Spasticity, Overactive Bladder, Cervical Dystonia, Blepharospasm, and Others}, and Aesthetics {Forehead Wrinkles, Glabellar Lines, Crow's Feet, and Others}), By Type (Botulinum Toxin Type A and Botulinum Toxin Type B), By End-user (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others), and Regional Forecast, 2023-2030

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI107507

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Overview of the Number of Botulinum Toxin Procedures, By Key Countries
    2. Overview of the Regulatory Scenario, By Key Countries/Regions
    3. Pricing Analysis
    4. Overview of the Types of Botulinum Toxin
    5. Pipeline Analysis, Key Players
    6. Key Industry Developments
    7. Overview of Therapeutic Applications of Botulinum Toxin and Recent Regulatory Approvals
    8. Overview of the Reimbursement Scenario, By Key Countries/Key Regions
    9. Impact of COVID-19 on the Middle East & Africa Botulinum Toxin Market
  5. Middle East & Africa Botulinum Toxin Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutics
        1. Chronic Migraine
        2. Spasticity
        3. Overactive Bladder
        4. Cervical Dystonia
        5. Blepharospasm
        6. Others
      2. Aesthetics
    2. Market Analysis, Insights and Forecast – By Type
      1. Botulinum Toxin Type A
      2. Botulinum Toxin Type B
    3. Market Analysis, Insights and Forecast – By End-user
      1. Specialty & Dermatology Clinics
      2. Hospitals & Clinics
      3. Others 
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC Countries
        1. By Application
      2. South Africa
        1. By Application
      3. Rest of Middle East & Africa
        1. By Application
  6. Competitive Analysis
    1. Middle East & Africa Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. AbbVie Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Ipsen Pharma
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Merz Pharma
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Medytox
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. GALDERMA
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. HUGEL, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Evolus, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Revance Therapeutics, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Supernus Pharmaceuticals, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Table 01: Middle East & Africa Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 02: Middle East & Africa Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

Table 03: Middle East & Africa Botulinum Toxin Market Revenue (USD billion) Forecast, By Type, 2019–2030

Table 04: Middle East & Africa Botulinum Toxin Market Revenue (USD billion) Forecast, By End User, 2019–2030

Table 05: Middle East & Africa Botulinum Toxin Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019–2030

Table 06: GCC Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 07: GCC Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

Table 08: South Africa Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 09: South Africa Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

Table 10: Rest of Middle East & Africa Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 11: Rest of Middle East & Africa Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

 

 

Middle East & Africa Botulinum Toxin Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 100
Consulting Services
    How will you benefit from our consulting services ?